Summary
- A burgeoning gray market for peptides, fueled by cryptocurrency, has exceeded an annual run rate of $100 million, as reported by Chainalysis.
- This growth is linked to the popularity of the "looksmaxxing" trend and increased interest in weight-loss peptides.
- Some peptide suppliers have been traced back to Chinese chemical manufacturers previously involved in the sale of drug precursors.
According to a report from Chainalysis released on Thursday, the gray market for peptides, supported by cryptocurrency transactions, has reached an impressive annual run rate of over $100 million, primarily through Bitcoin and stablecoin payments.
The research indicated that cryptocurrency transactions directed to peptide vendors surged from approximately $12 million in Q4 2025 to $32 million in Q1 2026, marking a significant 159% increase. The firm anticipates the market will process around $39 million in the upcoming second quarter.
Chainalysis stated, “What started as a discreet underground network of biohackers using cryptocurrency to navigate around traditional barriers has evolved into a financial powerhouse. This transformation has been driven initially by a newfound political acceptance and later by the viral phenomenon known as 'looksmaxxing', leading to a significant rise in the on-chain peptide market.”
Looksmaxxing is a trend popularized on social media that emphasizes enhancing physical attractiveness through various means, including fitness, grooming, diet, supplements, and cosmetic procedures. In contrast to biohacking, which seeks to improve health and longevity, looksmaxxing is primarily concerned with appearance enhancement.
Peptides, which are short chains of amino acids, are utilized in both medical and cosmetic applications, including the active components in well-known weight-loss medications like Ozempic and Wegovy. Although the availability and pricing of these medications have improved under President Trump's administration, the demand for less expensive alternatives has led to an expanding network of overseas suppliers distributing unbranded peptide products directly to consumers.
Unlike earlier online black markets such as the Silk Road, Chainalysis noted that gray markets gained traction during the Make America Healthy Again movement and the rising interest in alternative health solutions, accelerating particularly in early 2026. The firm estimates that this market is now processing tens of millions of dollars in cryptocurrency quarterly, positioning it to exceed a $100 million annual rate.
The report indicated that many vendors prefer to use Bitcoin and stablecoins due to restrictions imposed by banks and payment processors on transactions involving unapproved pharmaceuticals. Larger operators are increasingly leaning towards stablecoins, which are typically pegged to the dollar, thus mitigating exposure to the volatility of cryptocurrency prices.
“This inclination for stability is especially evident among wholesale vendors,” Chainalysis remarked. “When analyzing vendors with average deposits of $1,000 or more, the asset composition significantly shifts towards stablecoins—this is likely a strategic decision to protect large supply chain orders from the unpredictable price fluctuations in the broader crypto landscape.”
Additionally, the firm has identified several Chinese chemical producers that have shifted to peptide sales after previously supplying precursors for fentanyl and amphetamines, including Shanghai Sigma Audley and Bigreat Technology.
“By entering the gray market for peptides, these suppliers based in China are now able to sell highly sought-after finished products directly to consumers,” the report added. “This direct-to-consumer strategy enables them to eliminate intermediary cartels, retain the full retail profit margin, and significantly boost their revenue while reducing legal risks.”
Chainalysis did not respond immediately to a request for comment from Decrypt.